Monitoring and follow-up of patients

The availability of enzyme replacement therapy for Fabry disease has had a major impact on the organization of patient care. Many countries have produced expert guidelines outlining the recommended requirements for investigation, treatment and follow-up of patients and their families. This chapter summarizes the standards of care that operate in some of the major centres that contribute patient data to the FOS – Fabry Outcome Survey – database.